BioWorld

Oct. 24, 2006

Stiefel Plans $640M Acquisition Of Dermatology Firm Connetics

Privately held Stiefel Laboratories Inc.'s acquisition of Connetics Corp. for $640 million represents a happy ending - or beginning - for the firm previously known as Connective Therapeutics Inc. (BioWorld Today) Read More

Replidyne's Faropenem Denied As FDA Seeks Superiority Trials

NIH Directors Encouraged About Direction Of Research

Lexicon Adds $40M For Research, Pipeline Work

Other News To Note

Clinic Roundup

23andme founder-led group outbids Regeneron for company

BioWorld

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2025.

Elevidys’ second liver death hits Sarepta, sends DMD ripples

BioWorld

How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 18, 2025.

3D representation of tumor microenvironment

EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment

BioWorld Science

Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...